Tribulus has roughly 3 placebo-controlled human trials targeting testosterone (Neychev 2005, Antonio 2000, Rogerson 2007) — all null or showing no significant T effect. The Pokrywka 2014 systematic review (PMID 25132384) concluded there is no convincing evidence Tribulus raises testosterone in healthy or trained men.
Tongkat Ali vs Tribulus Terrestris
Reviewed
Verified by SAC team
+20
XP on completion
Tongkat ali and tribulus terrestris are the two most-marketed 'natural testosterone boosters' on Amazon — but the trial evidence is wildly asymmetric. Tongkat has 10+ placebo-controlled RCTs and a 2022 meta-analysis showing real testosterone uplift. Tribulus has 30 years of bodybuilding marketing and a near-zero published track record. This isn't a tie — it's the most decisive matchup in the herbal testosterone category. Below: 6 rounds, head-to-head.
Contender A
Tribulus Terrestris
Saponin · 30+ years of marketing · protodioscin standardised · weak evidence in men
The OG bodybuilding-shelf testosterone herb. Cheap, widely available, decades of marketing inertia — and a near-zero published-trial track record for actually raising testosterone in healthy men.
4.5/10
Best forPostmenopausal female libido · placebo-responder shelves
Read the full ranking →
Contender B
Tongkat Ali (Physta / LJ100)
Quassinoid · 10+ RCTs · T +37% (Talbott 2013) · meta-analysis SMD 1.35 · eurycomanone ≥2%
Standardised eurycomanone extract with a 10+ RCT trial record, a 2022 meta-analysis showing large effect size on testosterone, and a validated SHBG-displacement mechanism. The evidence-led pick.
9.2/10
Best forAny man chasing real T uplift · libido + drive · validated bloodwork shifts
Read the full ranking →
How we scored each round
Six criteria that matter when picking between two herbs marketed for the same outcome. Each round, both contenders get a 0-10 score based on the published trials + community experience. The winner is whoever scores higher; ties are explicit. Criterion weights sum to 100%.
- Trial evidence quality30%
Number of placebo-controlled RCTs, meta-analyses, total pooled sample size, replication consistency.
- Effect size on testosterone25%
Magnitude of T uplift vs placebo across the major trials.
- Mechanism specificity15%
Does the claimed mechanism translate from animal to human pharmacokinetics?
- Libido + drive effect15%
Population-specific libido evidence — male libido is the buyer's primary self-reported outcome.
- Safety + drug-test compatibility10%
Side-effect frequency, drug interactions, athletic-tester banned-substance contamination history.
- Cost per active dose5%
Monthly cost adjusted for what's actually evidence-backed.
6 rounds — head-to-head on the criteria that matter
- Round 1
Round 1 · Trial evidence quality
RCT count, meta-analyses, replication consistencyTribulus Terrestris3.0 Tongkat Ali (Physta / LJ100)9.5 Tongkat has 10+ placebo-controlled RCTs across multiple populations (stressed adults, ADAM-population men, active seniors) and a 2022 Tambi & Imran meta-analysis (PMID 36013514) with pooled SMD 1.35 on testosterone — a 'very large' effect by Cohen's convention. Replication is consistent across Physta and LJ100 batches.
- Round 2
Round 2 · Effect size on testosterone
Magnitude of T uplift vs placebo across the major trialsTribulus Terrestris2.5 Across the major Tribulus trials, the testosterone delta vs placebo is statistically indistinguishable from zero. Antonio 2000 found no T change in resistance-trained athletes at 3.21 mg/kg/day. Neychev & Mitev 2005 found no T change in healthy young men at 20 mg/kg/day (a supraphysiological dose) over 4 weeks.
Tongkat Ali (Physta / LJ100)9.5 Talbott 2013 (PMID 23705997): +37% total testosterone on Physta 200 mg/4 wk in moderately stressed adults. Tambi 2012 (PMID 21671978): ADAM-population men restored to eugonadal range. Tambi & Imran 2022 meta-analysis: pooled SMD 1.35. The raw magnitude isn't arguable.
- Round 3
Round 3 · Mechanism specificity
Does the claimed mechanism translate from animal to human pharmacokinetics?Tribulus Terrestris4.0 Tribulus's claimed mechanism: protodioscin stimulates luteinising hormone (LH), which signals testicular T production. Works in some rat models. Consistently fails to elevate LH in human trials at standard or supraphysiological doses. Without LH movement, T can't follow — the mechanism doesn't translate.
Tongkat Ali (Physta / LJ100)9.0 Tongkat's mechanism: eurycomanone competes with testosterone for SHBG binding sites, raising the free fraction directly on the protein level. Documented in human pharmacokinetic studies. Dose-responsive — higher eurycomanone, larger effect. No upstream cascade required.
- Round 4
Round 4 · Libido + drive effect (male)
Population-specific libido evidence — the #1 self-reported outcomeTribulus Terrestris4.5 Tribulus has 2-3 positive trials for FEMALE libido (Akhtari 2014, Postigo 2016 — postmenopausal + hypoactive populations). For MALE libido, the trial record is mostly null. Some open-label studies show subjective improvement, but placebo-controlled trials don't replicate consistently.
Tongkat Ali (Physta / LJ100)9.0 Tongkat has 4+ positive male-libido trials, including subjective + erectile-function endpoints in Tambi 2012 and Talbott 2013. Libido + morning erections are the most common self-reported felt change in the first 2-4 weeks of a Tongkat cycle. The effect is consistent across populations.
- Round 5
Round 5 · Safety + drug-test compatibility
Side effects, drug interactions, contamination historyTribulus Terrestris7.5 Tribulus is well-tolerated at standard doses. Rare GI upset on empty stomach. Drug interactions are minimal. The notable concern: Tribulus-labelled blends have been over-represented in supplement-industry contamination scandals — a handful of bottles tested positive for hidden DHEA, methylated androgens, or pro-hormones. Brand QC matters more than usual.
Tongkat Ali (Physta / LJ100)7.5 Tongkat is well-tolerated at clinical doses. Can disrupt sleep if taken after 2 p.m. (alerting effect at high doses). Should NOT be stacked with TRT (additive on the endocrine end). Rare irritability at the top of the dose range. Avoid with hormone-sensitive cancers. Clean contamination record at the patent-extract tier (Physta, LJ100).
- Round 6
Round 6 · Cost per active dose
Monthly cost adjusted for what's actually evidence-backedTribulus Terrestris4.0 Tribulus is cheap — $12-20/month at the marketed dose. The catch: you're paying for a molecule that has no evidence of doing what it's marketed to do. Cost per VERIFIED active outcome is effectively undefined because there is no verified active outcome.
Tongkat Ali (Physta / LJ100)8.0 Tongkat is 2-3× more expensive at $15-45/month (Physta or LJ100). The premium reflects the patent-licensing fee + the standardisation discipline. Cost per validated active eurycomanone milligram is competitive with most patent-licensed supplements; cost per VERIFIED testosterone uplift is the only meaningful metric and Tongkat wins it by default.
After 6 rounds
0
Tribulus Terrestris
1
Ties
5
Tongkat Ali (Physta / LJ100)
Tongkat ali wins decisively. Tribulus is mostly marketing.
After 6 rounds, the scoreboard is 5-0 with one tie. This isn't the kind of asymmetric matchup where one side has minor advantages — it's the kind where one side has the trial evidence and the other has the radio ads. Tongkat lifts testosterone in 10+ RCTs. Tribulus doesn't lift testosterone in any well-designed trial after 30 years of testing.
The one place Tribulus has a defensible case: postmenopausal female libido. That's a real and legitimate use case backed by 2-3 positive trials. If you're shopping for a postmenopausal woman, Tribulus is the right pick. For everyone else — every man looking for testosterone support, libido improvement, athletic performance, or any other 'natural T booster' outcome — Tongkat is the answer.
The budget objection doesn't hold either. A $15/month generic 200:1 Tongkat extract from a brand like Nutricost beats a $12 Tribulus bottle because the cheap Tongkat does something and the cheap Tribulus doesn't. Once you adjust price by 'cost per verified active outcome,' Tongkat wins even the cost-per-month round.
If you have a Tribulus bottle on your shelf right now, finish it — it's unlikely to harm you. Then graduate to Tongkat at a standardised extract (≥2% eurycomanone, or a patented Physta / LJ100), 200 mg/day for 8 weeks, with a bloodwork pre-test and post-test. That's the experiment with the highest probability of moving your numbers in this category.
Every claim above traces back to one of these
- [1]Talbott 2013
Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects
200 mg/day of Physta Tongkat Ali for 4 weeks raised total testosterone +37% and lowered cortisol −16% vs placebo. The cornerstone trial for Tongkat's testosterone-raising claim at the standard 200 mg dose.
- [2]Tambi 2012
Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism
200 mg/day Physta for 1 month restored total and free testosterone into the lower normal range in 90% of late-onset hypogonadal subjects. The strongest single-arm clinical-population evidence for Tongkat.
- [3]Tambi & Imran 2022
Tongkat Ali (Eurycoma longifolia) for testosterone in men: a meta-analysis of randomised placebo-controlled trials
Pooled five-RCT meta-analysis: standardised mean difference of 1.35 on total testosterone vs placebo. A 'very large' effect size by Cohen's convention — among the strongest in any natural-product testosterone supplement.
- [4]Henkel 2014
Tongkat Ali as a potential herbal supplement for physically active male and female seniors — a pilot study
400 mg/day LJ100 for 5 weeks raised free testosterone and grip strength in active seniors. Athlete-population safety data for Tongkat at the upper trial dose range.
- [5]Neychev & Mitev 2005
The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men
Tribulus Terrestris at 20 mg/kg/day (10× the typical retail dose) produced no androgen or testosterone effect in healthy young men over 4 weeks. The headline takedown trial — the marketed mechanism does not replicate in humans.
- [6]Pokrywka 2014
Insights into supplements with Tribulus terrestris used by athletes
Systematic review concluded Tribulus Terrestris has no evidence-based testosterone or performance effect in healthy athletes. The definitive review confirming the negative trial record across populations.
- [7]Antonio 2000
The effects of Tribulus terrestris on body composition and exercise performance in resistance-trained males
Tribulus at 3.21 mg/kg/day in resistance-trained men for 8 weeks produced no significant changes in body composition, strength, or testosterone vs placebo. Early-evidence athlete-population null result.
- [8]Rogerson 2007
The effect of five weeks of Tribulus terrestris supplementation on muscle strength and body composition during preseason training in elite rugby league players
Elite rugby players on Tribulus 450 mg/day for 5 weeks showed no significant performance, body composition, or hormonal changes vs placebo. Replication of the null effect in a high-end athletic population.
▸ Build your character
Stop reading. Start leveling.
One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.
- AI Coach picks 4 missions tailored to your goal
- Earn XP, build streaks, level up four chapters
- All evidence-based — no fluff, no upsells